Anouk Dev
Overview
Explore the profile of Anouk Dev including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
525
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shrestha A, Elliott S, Abasszade J, Wu K, Worland T, Simpson I, et al.
Case Rep Gastroenterol
. 2025 Feb;
19(1):96-106.
PMID: 39995754
Introduction: Turmeric is a common spice used in traditional Chinese and Ayurvedic medicine for a variety of purported health benefits. Recent concerns have arisen regarding turmeric-induced liver injury linked to...
2.
Abdelmalak J, Strasser S, Ngu N, Dennis C, Sinclair M, Majumdar A, et al.
Cancers (Basel)
. 2024 Sep;
16(17).
PMID: 39272868
Percutaneous ablation is recommended in Barcelona Clinic Liver Cancer (BCLC) stage 0/A patients with HCC ≤3 cm as a curative treatment modality alongside surgical resection and liver transplantation. However, trans-arterial...
3.
Wigg A, Tibballs J, Woodman R, Stuart K, Le H, Roberts S, et al.
BMC Cancer
. 2024 Jul;
24(1):813.
PMID: 38973009
Background: Therapeutic options for early-stage hepatocellular carcinoma (HCC) in individual patients can be limited by tumor and location, liver dysfunction and comorbidities. Many patients with early-stage HCC do not receive...
4.
Abdelmalak J, Strasser S, Ngu N, Dennis C, Sinclair M, Majumdar A, et al.
Cancers (Basel)
. 2024 Jun;
16(11).
PMID: 38893086
The management of early-stage hepatocellular carcinoma (HCC) is complex, with multiple treatment strategies available. There is a paucity of literature regarding variations in the patterns of care and outcomes between...
5.
Tan N, Ngu N, Worland T, Lee T, Abrahams T, Freeman E, et al.
Hepatol Commun
. 2024 May;
8(5).
PMID: 38696372
Background: The benefits of regular surveillance imaging for cholangiocarcinoma in patients with primary sclerosing cholangitis (PSC) are unclear. Hence, we aimed to evaluate the impact of regular magnetic resonance cholangiopancreatography...
6.
Hui S, Nguyen A, Le S, Dev A, Bell S
Intern Med J
. 2024 Apr;
54(8):1360-1368.
PMID: 38666599
Background: Ultrasound surveillance for hepatocellular carcinoma (HCC) may improve early tumour detection but may additionally result in surveillance-related harm through increased evaluation of non-HCC lesions. The incidence of these outcomes...
7.
Abdelmalak J, Strasser S, Ngu N, Dennis C, Sinclair M, Majumdar A, et al.
Cancers (Basel)
. 2023 Dec;
15(24).
PMID: 38136287
The optimal treatment approach in very-early and early-stage hepatocellular carcinoma (HCC) is not precisely defined, and there is ambiguity in the literature around the comparative efficacy of surgical resection versus...
8.
Hui S, Bell S, Le S, Dev A
Med J Aust
. 2023 Oct;
219(9):432-438.
PMID: 37803907
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death worldwide, and is increasing in incidence in Australia. For most people with cirrhosis and chronic hepatitis B, HCC screening and...
9.
Hui S, Sane N, Wang A, Wan L, Bell S, Le S, et al.
J Telemed Telecare
. 2023 Apr;
31(1):64-72.
PMID: 37032467
Background: Real-world hepatocellular carcinoma (HCC) surveillance uptake remains suboptimal, despite evidence that surveillance is associated with lower cancer-related mortality in patients with cirrhosis and chronic hepatitis B. We aimed to...
10.
Maharaj A, Lubel J, Lam E, Clark P, Duncan O, George J, et al.
Hepatol Commun
. 2022 Sep;
6(11):3260-3271.
PMID: 36153817
Although there are several established international guidelines on the management of hepatocellular carcinoma (HCC), there is limited information detailing specific indicators of good quality care. The aim of this study...